Atomoxetine for the treatment of pediatric nocturnal enuresis

被引：13

作者：

Shatkin, JP ^{[1
]}

机构：

[1] Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA

来源：

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | 2004年 / 14卷 / 03期

关键词：

D O I：

10.1089/1044546042389190

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Current treatments for pediatric nocturnal enuresis rely upon the use of behavioral interventions, such as enuresis alarms, and pharmacological interventions, such as antidiuretic hormone analogs, tricyclic antidepressants, and anticholinergics. However, a considerable number of patients do not respond fully to any of these interventions, in spite of optimal behavioral management and medication dosing. This report describes 4 children with attention deficit hyperactivity disorder (ADHD) comorbid with nocturnal enuresis. Each child was treated with atomoxetine for ADHD and experienced serendipitous resolution of enuresis.

引用

页码：443 / 447

页数：5

共 29 条

[1] Abdelghany S, 2001, Urol Nurs, V21, P401
[2] ABDELGHANY S, 2001, UROL NURS, V21, P410
[3] [Anonymous], 1994, AM PSYCHIATR ASSOC
[4] Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in Attention Deficit/Hyperactivity Disorder
Bymaster, FP
Katner, JS
Nelson, DL
Hemrick-Luecke, SK
Threlkeld, PG
Heiligenstein, JH
Morin, SM
Gehlert, DR
Perry, KW
[J]. NEUROPSYCHOPHARMACOLOGY, 2002, 27 (05) : 699 - 711
[5] Cigna R M, 2002, Pediatr Med Chir, V24, P363
[6] Cossio SE, 2002, SOUTH MED J, V95, P183
[7] DAHL RE, 1998, TXB PEDIAT NEURPSYCH, P821
[8] De Grazia E, 1999, Minerva Pediatr, V51, P149
[9] Djurhuus Jens C, 2002, Curr Opin Urol, V12, P317, DOI 10.1097/00042307-200207000-00010
[10] El Hemaly A K, 1998, Int Urogynecol J Pelvic Floor Dysfunct, V9, P129

← 1 2 3 →